Ramalingam SS - Search Results

1

Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.

Park D, Anisuzzaman ASM, Magis AT, Chen G, Xie M, Zhang G, Behera M, Sica GL, Ramalingam SS, Owonikoko TK, Deng X. Park D, et al. Among authors: ramalingam ss. Theranostics. 2021 Jul 25;11(17):8500-8516. doi: 10.7150/thno.60349. eCollection 2021. Theranostics. 2021. PMID: 34373755 Free PMC article.

2

Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database.

Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. J Clin Oncol. 2007 Dec 10;25(35):5570-7. doi: 10.1200/JCO.2007.12.5435. J Clin Oncol. 2007. PMID: 18065729

3

Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor.

Harichand-Herdt S, Ramalingam SS. Harichand-Herdt S, et al. Among authors: ramalingam ss. Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):217-23. doi: 10.1053/j.semtcvs.2008.09.005. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038731 Review.

4

Combined inhibition of vascular endothelial growth factor and epidermal growth factor signaling in non-small-cell lung cancer therapy.

Pakkala S, Ramalingam SS. Pakkala S, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Mar;10 Suppl 1:S17-23. doi: 10.3816/CLC.2009.s.003. Clin Lung Cancer. 2009. PMID: 19362942 Review.

5

Vorinostat increases carboplatin and paclitaxel activity in non-small-cell lung cancer cells.

Owonikoko TK, Ramalingam SS, Kanterewicz B, Balius TE, Belani CP, Hershberger PA. Owonikoko TK, et al. Among authors: ramalingam ss. Int J Cancer. 2010 Feb 1;126(3):743-55. doi: 10.1002/ijc.24759. Int J Cancer. 2010. PMID: 19621389 Free PMC article.

6

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

7

Preoperative therapy for early-stage NSCLC: opportunities and challenges.

Owonikoko TK, Khuri FR, Ramalingam SS. Owonikoko TK, et al. Among authors: ramalingam ss. Oncology (Williston Park). 2009 Sep;23(10):886, 889, 892. Oncology (Williston Park). 2009. PMID: 19839430 Free article. No abstract available.

8

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.

Ramalingam SS, Maitland ML, Frankel P, Argiris AE, Koczywas M, Gitlitz B, Thomas S, Espinoza-Delgado I, Vokes EE, Gandara DR, Belani CP. Ramalingam SS, et al. J Clin Oncol. 2010 Jan 1;28(1):56-62. doi: 10.1200/JCO.2009.24.9094. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933908 Free PMC article. Clinical Trial.

9

Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.

Ramalingam SS, Belani CP. Ramalingam SS, et al. Curr Opin Oncol. 2010 Mar;22(2):79-85. doi: 10.1097/CCO.0b013e328335a583. Curr Opin Oncol. 2010. PMID: 20009926 Review.

10

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer.

Ramalingam SS, Foster J, Gooding W, Evans T, Sulecki M, Belani CP. Ramalingam SS, et al. Cancer. 2010 Mar 1;116(5):1344-9. doi: 10.1002/cncr.24753. Cancer. 2010. PMID: 20082454 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters